SF 4486 Minnesota Senate · 2025-2026 Regular Session

Pharmacists authorization to initiate, prescribe, administer, and dispense certain drugs for the treatment of opioid use disorder

This bill expands the scope of practice for pharmacists in Minnesota by authorizing them to initiate, prescribe, administer, and dispense certain medications specifically for treating opioid use disorder. The legislation directly affects licensed pharmacists and pharmacist interns, allowing them to manage drug therapy for addiction treatment under established protocols or collaborative practice agreements with other healthcare providers. Key provisions include modifying the legal definition of a "practitioner" to include pharmacists authorized for these specific treatments and adjusting disciplinary grounds for pharmacists to reflect their expanded responsibilities. The bill also requires documentation of any therapy changes in patient medical records and maintains oversight through collaboration with dentists, physicians, nurse practitioners, and other licensed healthcare professionals.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 17, 2026 Last action Mar 17, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Mar 17, 2026
Committee
Referred to Health and Human Services
upper
Mar 17, 2026
Introduced
Introduction and first reading
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of John Hoffman
John Hoffman
DDemocratic-Farmer-Labor
MN
34